4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001522780-26-000002
Director acquired 61,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD Director | 2026-03-15 | Option exercise | +35,500 | 84,624 | D: show line 1 in the form | ||
| Kaye Edward M. MD Director | 2026-03-15 | Option exercise | +26,250 | 110,874 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD Director | 2026-03-15 | Option exercise · Restricted Stock Units | −35,500 | 35,500 | D: show line 3 in the form | |||||
| Kaye Edward M. MD Director | 2026-03-15 | Option exercise · Restricted Stock Units | −26,250 | 52,500 | D: show line 4 in the form |
Loading xslF345X05/form4-03172026_090329.xml…